Zivo Bioscience reports shareholder votes: directors elected, equity plan approved, auditor ratified

Zivo Bioscience, Inc.

All five director nominees elected with >95% votes for (excluding broker non-votes).
Ratification of Wolinetz, Lafazan & Company as auditor approved with 98% of votes cast.
2021 Equity Incentive Plan approved with ~90% of votes for (excluding broker non-votes).
Advisory say-on-pay approved with ~94% of votes for (excluding broker non-votes).
60.6% of outstanding shares represented at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.